A detailed history of Congress Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Congress Wealth Management LLC holds 191,241 shares of ABBV stock, worth $35 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
191,241
Previous 166,981 14.53%
Holding current value
$35 Million
Previous $28.6 Million 31.86%
% of portfolio
0.52%
Previous 0.47%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $3.97 Million - $4.84 Million
24,260 Added 14.53%
191,241 $37.8 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $8.07 Million - $9.43 Million
52,161 Added 45.43%
166,981 $28.6 Million
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $1.63 Million - $1.86 Million
-10,187 Reduced 8.15%
114,820 $20.9 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $2.95 Million - $3.33 Million
21,464 Added 20.73%
125,007 $19.4 Million
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $560,944 - $649,375
4,199 Added 4.23%
103,543 $15.4 Million
Q2 2023

Jul 13, 2023

BUY
$132.51 - $164.9 $164,577 - $204,805
1,242 Added 1.27%
99,344 $13.4 Million
Q1 2023

Apr 14, 2023

BUY
$144.61 - $166.54 $175,990 - $202,679
1,217 Added 1.26%
98,102 $15.6 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $324,751 - $389,462
2,348 Added 2.48%
96,885 $15.7 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $303,180 - $347,727
2,259 Added 2.45%
94,537 $12.7 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $300,837 - $382,462
-2,186 Reduced 2.31%
92,278 $14.1 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $226,609 - $281,158
-1,717 Reduced 1.79%
94,464 $15.3 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $10.3 Million - $13.1 Million
96,181 New
96,181 $13 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Congress Wealth Management LLC Portfolio

Follow Congress Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Congress Wealth Management LLC with notifications on news.